Skip to Sidebar Skip to Content

Abingworth

Life sciences investor funding biotech companies developing new therapeutics

  • Venture capital
  • London
Type
Venture capital
Based in
London
Stages
Pre-seed, Seed, Series A, Series B+, Growth
Sector focus
Sector-agnostic
Cheque size
Above €3M
Fund size
Undisclosed
Founded
1987

A life sciences investment firm founded in 1987 and headquartered in London, with further offices in New York and San Francisco. It backs entrepreneurs turning scientific discoveries into new medicines, concentrating on biotech and biopharma companies.

Early-stage venture investment is central to its approach, and it also uses venture investments in public equities (VIPEs) and clinical co-development deals, where it funds late-stage trials of drug candidates. The firm says it has invested in more than 100 biotech companies since it was established.

Add this profile to your website

Show this card on your own site. It reads “As seen on EP+” and links back to this page.

Paste it anywhere your site accepts HTML. Is this your organisation? Request an update if the card is out of date.

← All investors · Is this your organisation? Request an update

More investors in the directory

Subscribe to Newsletter

UK startup news, founder stories and funding insight, straight to your inbox every week. Free.